rs10887721

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_000429.3(MAT1A):​c.92-9C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 1,587,578 control chromosomes in the GnomAD database, including 22,191 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 5159 hom., cov: 32)
Exomes 𝑓: 0.14 ( 17032 hom. )

Consequence

MAT1A
NM_000429.3 intron

Scores

2
Splicing: ADA: 0.4505
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.300

Publications

9 publications found
Variant links:
Genes affected
MAT1A (HGNC:6903): (methionine adenosyltransferase 1A) This gene catalyzes a two-step reaction that involves the transfer of the adenosyl moiety of ATP to methionine to form S-adenosylmethionine and tripolyphosphate, which is subsequently cleaved to PPi and Pi. S-adenosylmethionine is the source of methyl groups for most biological methylations. The encoded protein is found as a homotetramer (MAT I) or a homodimer (MAT III) whereas a third form, MAT II (gamma), is encoded by the MAT2A gene. Mutations in this gene are associated with methionine adenosyltransferase deficiency. [provided by RefSeq, Jul 2008]
MAT1A Gene-Disease associations (from GenCC):
  • methionine adenosyltransferase deficiency
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 10-80285598-G-C is Benign according to our data. Variant chr10-80285598-G-C is described in ClinVar as Benign. ClinVar VariationId is 256108.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.44 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000429.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAT1A
NM_000429.3
MANE Select
c.92-9C>G
intron
N/ANP_000420.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAT1A
ENST00000372213.8
TSL:1 MANE Select
c.92-9C>G
intron
N/AENSP00000361287.3
MAT1A
ENST00000455001.1
TSL:5
c.26-9C>G
intron
N/AENSP00000414961.1

Frequencies

GnomAD3 genomes
AF:
0.216
AC:
32849
AN:
151980
Hom.:
5144
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.446
Gnomad AMI
AF:
0.181
Gnomad AMR
AF:
0.129
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0921
Gnomad FIN
AF:
0.111
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.142
Gnomad OTH
AF:
0.183
GnomAD2 exomes
AF:
0.138
AC:
34758
AN:
251282
AF XY:
0.136
show subpopulations
Gnomad AFR exome
AF:
0.456
Gnomad AMR exome
AF:
0.0758
Gnomad ASJ exome
AF:
0.181
Gnomad EAS exome
AF:
0.000870
Gnomad FIN exome
AF:
0.115
Gnomad NFE exome
AF:
0.145
Gnomad OTH exome
AF:
0.131
GnomAD4 exome
AF:
0.142
AC:
203208
AN:
1435480
Hom.:
17032
Cov.:
27
AF XY:
0.140
AC XY:
100100
AN XY:
715876
show subpopulations
African (AFR)
AF:
0.461
AC:
15238
AN:
33038
American (AMR)
AF:
0.0827
AC:
3697
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.179
AC:
4648
AN:
25958
East Asian (EAS)
AF:
0.000531
AC:
21
AN:
39574
South Asian (SAS)
AF:
0.103
AC:
8850
AN:
85684
European-Finnish (FIN)
AF:
0.115
AC:
6148
AN:
53410
Middle Eastern (MID)
AF:
0.170
AC:
974
AN:
5716
European-Non Finnish (NFE)
AF:
0.142
AC:
154902
AN:
1087960
Other (OTH)
AF:
0.147
AC:
8730
AN:
59456
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
7162
14324
21487
28649
35811
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5544
11088
16632
22176
27720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.216
AC:
32893
AN:
152098
Hom.:
5159
Cov.:
32
AF XY:
0.212
AC XY:
15745
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.446
AC:
18487
AN:
41464
American (AMR)
AF:
0.129
AC:
1968
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
590
AN:
3468
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5184
South Asian (SAS)
AF:
0.0914
AC:
440
AN:
4816
European-Finnish (FIN)
AF:
0.111
AC:
1174
AN:
10584
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.142
AC:
9632
AN:
67980
Other (OTH)
AF:
0.180
AC:
381
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1160
2320
3479
4639
5799
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
312
624
936
1248
1560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.171
Hom.:
850
Bravo
AF:
0.229
Asia WGS
AF:
0.0630
AC:
218
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Hepatic methionine adenosyltransferase deficiency Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
18
DANN
Benign
0.56
PhyloP100
0.30
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.45
dbscSNV1_RF
Benign
0.37
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10887721; hg19: chr10-82045354; API